BCAB - Bioatla  - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

BCAB is currently covered by 6 analysts with an average price target of $13.11. This is a potential upside of $10.76 (457.87%) from yesterday's end of day stock price of $2.35.

Bioatla 's activity chart (see below) currently has 8 price targets and 24 ratings on display. The stock rating distribution of BCAB is 82.35% BUY and 17.65% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 12.14 days.

Highest price target for BCAB is $12, Lowest price target is $12, average price target is $13.11.

Most recent stock forecast was given by RENI BENJAMIN from JMP on 28-Mar-2024.

Currently out of the existing stock ratings of BCAB, 14 are a BUY (82.35%), 3 are a HOLD (17.65%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

$9.65 (410.64%)

12

28 days ago

0/5 (0%)

$8.56 (248.84%)

Buy

87

1 years 28 days ago

1/2 (50%)

$29.63 (51.65%)

14

Hold

8

$5.65 (240.43%)

8

1 years 1 months 1 days ago

4/6 (66.67%)

$5.64 (238.98%)

71

Buy

20

$17.65 (751.06%)

25

1 years 8 months 15 days ago

0/2 (0%)

$13.39 (202.57%)

Buy

64

2 years 5 months 7 days ago

0/1 (0%)

$18.11 (39.46%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCAB (Bioatla ) average time for price targets to be met?

On average it took 12.14 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on BCAB (Bioatla ) with a proven track record?

TIAGO FAUTH

Which analyst has the current lower performing score on BCAB (Bioatla ) with a proven track record?

KAVERI POHLMAN

Which analyst has the most public recommendations on BCAB (Bioatla )?

Tiago Fauth works at CREDIT SUISSE and has 7 price targets and 4 ratings on BCAB

Which analyst is the currently most bullish on BCAB (Bioatla )?

Swayampakula Ramakanth with highest potential upside - $17.65

Which analyst is the currently most reserved on BCAB (Bioatla )?

Anupam Rama with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?